uft 100 mg/224 mg capsulas duras
merck, s.l. - tegafur, uracilo - excipientes: laurilsulfato de sodio - antimetabolitos - análogos de las pirimidinas - tegafur, combinaciones con
utefos 400 mg capsulas duras
mylan pharmaceuticals, s.l. - tegafur - cÁpsula dura - 400 mg - tegafur 400 mg - tegafur
uft (tegafur 100 mg - uracilo 224 mg) capsulas
merck, s.a. - tegafur -uracilo - capsula - 100 mg/224 mg
paltegafur 100mg/224mg capsula
palmagyar s.a. - capsula - por capsula - tegafur, combinaciones
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
tegafur + uracilo 100/224 mg 100 mg + 224 mg capsula
palmagyar s.a. - capsula
tegafur + uracilo 100mg + 224mg capsula
laboratorios ac farma s.a. - capsula
tegafur + uracilo 100mg + 224mg capsula
medifarma s.a. - capsula
tegafur + uracilo 100 mg + 224 mg capsula
laboratorios induquimica s.a. - capsula
asofurtal 100 mg -224 mg comprimidos recubiertos
representaciones nolver c.a. - tegafur -uracilo - comprimido recubierto - 100 mg-224 mg